Literature DB >> 182714

Recovery of applied human leukocyte interferon from the nasal mucosa of chimpanzees and humans.

P E Johnson, S B Greenberg, M W Harmon, B R Alford, R B Couch.   

Abstract

Intranasally applied human leukocyte interferon was recovered locally in 9 of 10 chimpanzees and 3 of 3 human volunteers tested. A 5- to 50-fold reduction in interferon was observed over 60 min.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 182714      PMCID： PMC274401          DOI： 10.1128/jcm.4.1.106-107.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  4 in total

Review 1.  Physiology of the nose.

Authors:  M Abramson; L A Harker
Journal:  Otolaryngol Clin North Am       Date:  1973-10       Impact factor: 3.346

2.  Inhibition of respiratory virus infection by locally applied interferon.

Authors:  T C Merigan; S E Reed; T S Hall; D A Tyrrell
Journal:  Lancet       Date:  1973-03-17       Impact factor: 79.321

3.  Clearance of inhaled particles from the human nose.

Authors:  D F Proctor; G Lundqvist
Journal:  Arch Intern Med       Date:  1973-01

4.  Atraumatic biopsy of nasal mucosa.

Authors:  B R Alford; R G Douglas; R B Couch
Journal:  Arch Otolaryngol       Date:  1969-08
  4 in total
  8 in total

1.  Antiviral activity of intranasally applied human leukocyte interferon.

Authors:  S B Greenberg; M W Harmon; P E Johnson; R B Couch
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

Review 2.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

Review 3.  Interferon: therapeutic fact or fiction for the '80s?

Authors:  G M Scott; D A Tyrrell
Journal:  Br Med J       Date:  1980-06-28

4.  Failure of human fibroblast interferon to protect against rhinovirus infection.

Authors:  G M Scott; S Reed; T Cartwright; D Tyrrell
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

Review 5.  Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.

Authors:  R B Pollard
Journal:  Drugs       Date:  1982 Jan-Feb       Impact factor: 9.546

6.  Purified interferon as protection against rhinovirus infection.

Authors:  G M Scott; R J Phillpotts; J Wallace; D S Secher; K Cantell; D A Tyrrell
Journal:  Br Med J (Clin Res Ed)       Date:  1982-06-19

7.  Human nasal epithelial cell culture system: evaluation of response to human interferons.

Authors:  M W Harmon; S B Greenberg; P E Johnson; R B Couch
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

8.  Pulmonary deposition and clearance of aerosolized interferon.

Authors:  P R Wyde; S Z Wilson; M J Kramer; C S Sun; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.